CymaBay Therapeutics Inc Stock Price. Everything You Need To Know About The CymaBay Therapeutics Inc Stock! CymaBay Therapeutics Inc Stock Price. Everything You Need To Know About The CymaBay Therapeutics Inc Stock!


CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. The company is headquartered in Newark California, California and currently employs 60 full-time employees. The company went IPO on 2014-01-16. The firm is focused on developing and providing access to therapies for patients with liver and other chronic diseases. The firm’s lead product candidate, seladelpar, is a potent and selective agonist of peroxisome proliferator activated receptor delta (PPARd), a nuclear receptor that regulates genes directly or indirectly involved in the synthesis of bile acids/sterols, metabolism of lipids and glucose, inflammation, and fibrosis. The company is focused on developing seladelpar for the treatment of primary biliary cholangitis (PBC), an autoimmune disease that causes progressive destruction of the bile ducts in the liver resulting in impaired bile flow (cholestasis) and inflammation. Its other product candidate, MBX-2982, targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.



CymaBay Therapeutics Inc Stock Price. Everything You Need To Know About The CymaBay Therapeutics Inc Stock! performance

  • Employees 60
  • Company HQ Newark California
  • Website https://www.cymabay.com/
  • Asset Type
  • Market Capitalization 0
  • Earnings Per Share
  • Dividends Per Share
  • Dividend Date
  • Quarterly Earnings Growth

Are you looking to invest in the stock market from Malaysia, Thailand, Indonesia, or Vietnam? Consider CymaBay Therapeutics, a promising stock in the healthcare industry. CymaBay Therapeutics is a biopharmaceutical company focused on developing breakthrough therapies for liver diseases. To invest in CymaBay Therapeutics from these countries, you’ll need to follow a few steps. Firstly, open an investment account with a brokerage that offers access to the US stock market. Then, fund your account using a convenient payment method available in your country. Once your account is ready, search for CymaBay Therapeutics’ ticker symbol (CBAY) and place an order to buy shares. To make informed investment decisions, Zorion, the leading investment platform, offers investment insights and recommendations about CymaBay Therapeutics. Additionally, Zorion provides educational materials and resources to help you enhance your investment knowledge, making it easier for you to invest confidently. Start investing in CymaBay Therapeutics today and explore the potential growth opportunities in the healthcare sector.


Explore More Investment Opportunities: